Swiss March Retail Sales Y/Y -0.1% vs. 0.2% expected and 0.2% prior.

NVDA's forward P/E of 25 beats S&P 500's 21.8, suggesting AI growth justifies its valuation.

CVLT dips 4.2% on hold rating; SNOW +3.4% on GPT 5.5. NVDA +3.6% on AI sentiment.

Biogen's Q1 revenue seen down 8.3% YoY. Last quarter beat, but peers up 11% while BIIB dips 3.9%.

HHH revenue down 36.5% despite beat, stock drops 20.9%. REAX revenue up 44.1% but stock down 26.2%.

FirstEnergy's Q1 earnings up 7.5% on infrastructure spend. Predictable returns via formula rates.

OXY's revenue fell 20.7%, missing estimates, yet its stock is up 21.5%. Peers saw mixed results, with E&P stocks up 11.7% avg.

Qatar offers 40% business support amid regional risks. IMF forecasts -8.6% GDP contraction.